PAM
KITE

Princeton Alpha Management’s Kite Pharma, Inc. KITE Stock Holding History

Princeton Alpha Management’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-7,880
Closed -$353K – 849
2016
Q4 		$353K Buy
+7,880
New +$387K 0.07% 408

Other funds holding KITE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Princeton Alpha Management's KITE Position: Q1 2017 in Review

Princeton Alpha Management sold out of Kite Pharma, Inc. (KITE) in Q1 2017, closing a stake of 7,880 shares — an estimated $353K sold.

Princeton Alpha Management first reported a position in KITE in Q4 2016 and held it in 1 quarter. The position peaked at $353K in Q4 2016. 209 funds tracked by Wall St. Rank hold KITE as of Q1 2017.

  • Princeton Alpha Management reported no remaining Kite Pharma, Inc. position as of Q1 2017 after selling out during the quarter.
  • Princeton Alpha Management sold 7,880 Kite Pharma, Inc. shares in Q1 2017, an estimated $353K.
  • Princeton Alpha Management first reported a position in Kite Pharma, Inc. in Q4 2016 and held it in 1 quarter.
  • Princeton Alpha Management's Kite Pharma, Inc. position peaked at $353K in Q4 2016.
  • 209 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q1 2017.

Based on Princeton Alpha Management's 13F filing for Q1 2017, filed 3 May 2017.